IL106255A0 - Method for isolating human blood cells - Google Patents

Method for isolating human blood cells

Info

Publication number
IL106255A0
IL106255A0 IL106255A IL10625593A IL106255A0 IL 106255 A0 IL106255 A0 IL 106255A0 IL 106255 A IL106255 A IL 106255A IL 10625593 A IL10625593 A IL 10625593A IL 106255 A0 IL106255 A0 IL 106255A0
Authority
IL
Israel
Prior art keywords
blood cells
human blood
isolating human
isolating
cells
Prior art date
Application number
IL106255A
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of IL106255A0 publication Critical patent/IL106255A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0641Erythrocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00Use of cells in diagnostics
    • C12N2503/02Drug screening
IL106255A 1993-04-23 1993-07-06 Method for isolating human blood cells IL106255A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5243393A 1993-04-23 1993-04-23

Publications (1)

Publication Number Publication Date
IL106255A0 true IL106255A0 (en) 1993-11-15

Family

ID=21977580

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106255A IL106255A0 (en) 1993-04-23 1993-07-06 Method for isolating human blood cells

Country Status (6)

Country Link
EP (1) EP0695346A1 (en)
JP (1) JPH08509377A (en)
AU (1) AU6559094A (en)
CA (1) CA2160871A1 (en)
IL (1) IL106255A0 (en)
WO (1) WO1994025571A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018648A1 (en) * 1992-03-23 1993-09-30 Baxter International Inc. In vitro-derived human neutrophil precursor cells
EP1017790A1 (en) * 1997-09-25 2000-07-12 GlycoTech Corp. Methods and compositions for binding hematopoietic stem cells
EP1047942A4 (en) * 1998-01-23 2002-10-30 Alexion Antibody Technologies Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
WO2007010941A1 (en) * 2005-07-20 2007-01-25 Kaneka Corporation Antigen and monoclonal antibody capable of recognizing the antigen
CA2676323A1 (en) 2007-01-18 2008-07-24 Suomen Punainen Risti, Veripalvelu Novel methods and reagents directed to production of cells
CA2712474A1 (en) 2008-02-21 2009-08-27 Baxter Healthcare S.A. Procedure for the generation of a high producer cell line for the expression of a recombinant anti-cd34 antibody
US9677042B2 (en) 2010-10-08 2017-06-13 Terumo Bct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
EP3068867B1 (en) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expanding cells in a bioreactor
JP6783143B2 (en) 2014-03-25 2020-11-11 テルモ ビーシーティー、インコーポレーテッド Passive replenishment of medium
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
JP7393945B2 (en) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド cell proliferation
JP2019000063A (en) * 2017-06-19 2019-01-10 東ソー株式会社 Method for exfoliating and recovering undifferentiated cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL54911A0 (en) * 1978-06-15 1978-08-31 Yeda Res & Dev Process for the fractionation of cells
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US5081030A (en) * 1989-04-25 1992-01-14 The Johns Hopkins University Release of cells from affinity matrices

Also Published As

Publication number Publication date
CA2160871A1 (en) 1994-11-10
EP0695346A1 (en) 1996-02-07
AU6559094A (en) 1994-11-21
WO1994025571A1 (en) 1994-11-10
JPH08509377A (en) 1996-10-08

Similar Documents

Publication Publication Date Title
EP0795007A4 (en) Bioengineered human blood cells
AU624464B2 (en) Skin treatment method
EP0820338A4 (en) Whole blood separation method and devices
AU6329296A (en) Electrolytic treatment device and method for using same
HU9301404D0 (en) Method for preparing medical preparatives
IL106255A0 (en) Method for isolating human blood cells
AU1624397A (en) Cryogenic well stimulation method
AU1712192A (en) Method for obtaining blood
IL130035A0 (en) Method for conversion of blood type
ZA965191B (en) Cell treatment
GB9422790D0 (en) Method for making stratified tissue
ZA962883B (en) Method for the microbial decontamination of blood platelets
GB9316369D0 (en) Diagnostic method
EP0722330A4 (en) Methods for analysis of human stem cells
GB2270752B (en) Diagnostic method
GB9317585D0 (en) Diagnostic method
IL107015A0 (en) Method for treatment of blood
IL107586A0 (en) Method for treatment of blood
AUPM970594A0 (en) Method and means for separating blood
GB9316836D0 (en) Human cell lines
DE4495155T1 (en) Diagnosis method
GB9303959D0 (en) Treatment method
GB9210170D0 (en) Diagnostic method
GB9222661D0 (en) Diagnostic method
GB9218197D0 (en) Diagnostic method